Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

917392-54-2Nilotinib impurity G

● In Stock

Catalogue No.:	VE006283
CAS No.:	917392-54-2
Mol. Formula:	C18H16N4O2
Mol. Weight:	320.35

Request a quote

Add to RFQ list

Additional information on CAS 917392-54-2

Parent drug

Nilotinib

IUPAC Name

Methyl 4-Methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzoate

Synonyms

Methyl 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic Acid Ester;

Smiles

CC1=C(C=C(C=C1)C(=O)OC)NC2=NC=CC(=N2)C3=CN=CC=C3

Description

It is an impurity present in Nilotinib which states that the anti-tumor activity and safety of nilotinib that is a KIT inhibitor utilized in the patients with metastatic melanoma harboring KIT alterations which are either mutations or amplifications.

References

Kondra, S. B., et al. “A Validated Stability-Indicative UPLC Method for Nilotinib Hydrochloride for the Determination of Process-Related and Degradation Impurities.” Journal of Chromatographic Science, vol. 52, no. 8, Sept. 2013, pp. 880–85, https://doi.org/10.1093/chromsci/bmt134.?Cho, Jin Hyun, et al. “Nilotinib in Patients with Metastatic Melanoma Harboring KIT Gene Aberration.” Investigational New Drugs, vol. 30, no. 5, Nov. 2011, pp. 2008–14, https://doi.org/10.1007/s10637-011-9763-9.?